Skip to content
Biotechnology, Defence

Research to merge human brain cells with AI secures national defence funding

Monash University 2 mins read

Monash University-led research into growing human brain cells onto silicon chips, with new continual learning capabilities to transform machine learning, has been awarded almost $600,000 AUD in the prestigious National Intelligence and Security Discovery Research Grants Program.

The new research program, led by Associate Professor Adeel Razi, from the Turner Institute for Brain and Mental Health, in collaboration with Melbourne start-up Cortical Labs, involves growing around 800,000 brain cells living in a dish, which are then “taught” to perform goal-directed tasks. Last year the brain cells’ ability to perform a simple tennis-like computer game, Pong, received global attention for the team’s research.

According to Associate Professor Razi, the research program’s work using lab-grown brain cells embedded onto silicon chips, “merges the fields of artificial intelligence and synthetic biology to create programmable biological computing platforms,” he said. 

“This new technology capability in future may eventually surpass the performance of existing, purely silicon-based hardware.

"The outcomes of such research would have significant implications across multiple fields such as, but not limited to, planning, robotics, advanced automation, brain-machine interfaces, and drug discovery, giving Australia a significant strategic advantage."

The project garnered funding from the prestigious Australian grant body because the new generation of applications of machine learning, such as self-driving cars and trucks, autonomous drones, delivery robots, intelligent hand-held and wearable devices, “will require a new type of machine intelligence that is able to learn throughout its lifetime,” Associate Professor Razi said.  

This “continual lifelong learning” means machines can acquire new skills without compromising old ones, adapt to changes, and apply previously learned knowledge to new tasks—all while conserving limited resources such as computing power, memory and energy. Current AI cannot do this and suffers from “catastrophic forgetting”. 

In contrast, brains excel at continual lifelong learning. 

The project’s aim is to grow human brain cells in a laboratory dish, called the DishBrain system, to understand the various biological mechanisms that underlie lifelong continual learning.

“We will be using this grant to develop better AI machines that replicate the learning capacity of these biological neural networks. This will help us scale up the hardware and methods capacity to the point where they become a viable replacement for in silico computing,“  Associate Professor Razi said. 

For media enquiries please contact:

Monash University
Tania Ewing
E: [email protected] 
T: 0408 378 422

For more Monash media stories, visit our news and events site 

For general media enquiries please contact:
Monash Media
E: [email protected]
T: +61 (0) 3 9903 4840

 


Contact details:

Tania Ewing
0408 378 422
[email protected] 

More from this category

  • Biotechnology
  • 04/12/2025
  • 09:35
Evinco Therapeutics Pty Ltd

Launch of Evinco Therapeutics: A pioneering biotech company advancing immune therapies for Alzheimer’s disease

Evinco Therapeutics is an Australian start-up on a mission to transform the treatment of Alzheimer’s disease and other neuroinflammatory conditions Melbourne, Australia, 4 December 2025 – An exciting chapter in medical innovation begins today with the official launch of Evinco Therapeutics Pty Ltd (“Evinco” or “Company”), a Melbourne-based biotechnology company developing advanced immune-based therapies for neurological disorders under the leadership of CEO and Executive Chair, Prof. Alan Trounson AO. Evinco is a spin-out from Cartherics Pty Ltd (“Cartherics”), allowing Cartherics to focus on its development programs in cancer and endometriosis. Evinco is raising capital to enable proof of concept studies.…

  • Biotechnology
  • 03/12/2025
  • 10:49
4DMedical Limited (ASX:4DX)

4DMedical secures US$10m CTVQ orders in Philips deal

Highlights• Philips will add CT:VQ™ to its North American product catalogue, backed by minimum contractual order commitment of approximately A$15m (US$10m) over two years • CT:VQ™ sales via Philips will be on full commercial terms • Philips to deploy dedicated sales and clinical specialists with CT:VQ™ targets across United States and Canada • Commercial launch announced at a breakfast session at the Radiological Society of North America (RSNA) annual meeting, the largest radiological conference in North America • Given the clinical and logistical advantages of CT:VQ™ over traditional nuclear VQ imaging modalities, 4DMedical expects to displace 100% of all nuclear…

  • Defence, Veterans Affairs
  • 03/12/2025
  • 10:30
Department of Veterans' Affairs

Media Release – Minister Keogh – Travel to United States

OFFICIAL THE HON MATT KEOGH MP MINISTER FOR VETERANS’ AFFAIRS MINISTER FOR DEFENCE PERSONNEL MEDIA RELEASE 2 DECEMBER 2025 TRAVEL TO UNITED STATES Today I will travel to the United States of America to represent Australia at the Honolulu Leadership Dialogue. The Honolulu Leadership Dialogue brings together parliamentarians, senior Australian and US defence officials, security experts and industry leaders to discuss the complex operating environment in the Indo-Pacific. It is convened by the Australian American Leadership Dialogue. The Dialogue provides an opportunity to take stock of the depth of the Australia‑US Alliance across security, trade, defence and technology and to…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.